匯控(00005.HK)宣派2019年第三次股息每普通股10美仙
匯豐控股(00005.HK)公布,今日(10月2日),董事會宣派2019年第三次股息每股普通股0.1美元。匯豐之普通股將於2019年10月10日在倫敦、香港、巴黎及百慕達除息報價,美國預託股份則於2019年10月10日在紐約除息報價。是次股息將於2019年11月20日派發予於2019年10月11日登記在冊的持有人。
是次股息將以美元、英鎊或港元,或該三種貨幣之組合(按英國匯豐銀行有限公司於2019年11月11日上午11時正或前後在倫敦所報之遠期匯率折算)派發。股東亦可選擇以股票代替股息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.